These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 16539730

  • 1. Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer.
    Schostak M, Krause H, Miller K, Schrader M, Weikert S, Christoph F, Kempkensteffen C, Kollermann J.
    BMC Urol; 2006 Mar 15; 6():7. PubMed ID: 16539730
    [Abstract] [Full Text] [Related]

  • 2. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
    Schostak M, Miller K, Krause H, Schrader M, Kempkensteffen C, Kollermann J.
    Cancer Detect Prev; 2006 Mar 15; 30(5):449-54. PubMed ID: 17067752
    [Abstract] [Full Text] [Related]

  • 3. [Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction].
    Tao ZH, Mao XL, Wang CH, Chen XD, Yu KY, Weng ZL, Hu YP, Zhang XH, Xie H, Wang OC, Song QT, Li CD, Chen ZG.
    Zhonghua Nan Ke Xue; 2007 Feb 15; 13(2):130-3. PubMed ID: 17345768
    [Abstract] [Full Text] [Related]

  • 4. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P, Lind K, Malentacchi F, Nesi G, Salvianti F, Villari D, Kubista M, Pazzagli M, Orlando C.
    Hum Pathol; 2008 Oct 15; 39(10):1474-82. PubMed ID: 18619642
    [Abstract] [Full Text] [Related]

  • 5. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z, Liu J, Li S, Shen W.
    Prostate; 2009 Sep 01; 69(12):1292-302. PubMed ID: 19462463
    [Abstract] [Full Text] [Related]

  • 6. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
    Barbero G, Destefanis P, Procida S, Mandili G, Ulliers D, Ceruti C, Fiori C, Maule MM, Fontana D, Giribaldi G, Turrini F.
    BJU Int; 2008 Dec 01; 102(11):1566-72. PubMed ID: 18549428
    [Abstract] [Full Text] [Related]

  • 7. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
    Antunes AA, Leite KR, Sousa-Canavez JM, Camara-Lopes LH, Srougi M.
    J Urol; 2009 Feb 01; 181(2):594-600. PubMed ID: 19084862
    [Abstract] [Full Text] [Related]

  • 8. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.
    Klecka J, Holubec L, Pesta M, Topolcan O, Hora M, Eret V, Finek J, Chottova-Dvorakova M, Babjuk M, Novak K, Stolz J.
    Anticancer Res; 2010 Feb 01; 30(2):665-70. PubMed ID: 20332487
    [Abstract] [Full Text] [Related]

  • 9. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
    Llanes L, Ferruelo A, Luján M, Pascual C, García-Mediero JM, Berenguer A.
    Prostate Cancer Prostatic Dis; 2005 Feb 01; 8(3):248-52. PubMed ID: 15897916
    [Abstract] [Full Text] [Related]

  • 10. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM, Thuler LC, Matos AR, Coutinho-Camillo CM, Soares FA, da Silva EA, Neves AF, Goulart LR, Gimba ER.
    Exp Mol Pathol; 2012 Feb 01; 92(1):13-9. PubMed ID: 21963599
    [Abstract] [Full Text] [Related]

  • 11. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z, Wenlu S.
    Prostate; 2008 Feb 01; 68(2):190-9. PubMed ID: 18076024
    [Abstract] [Full Text] [Related]

  • 12. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
    Fuessel S, Sickert D, Meye A, Klenk U, Schmidt U, Schmitz M, Rost AK, Weigle B, Kiessling A, Wirth MP.
    Int J Oncol; 2003 Jul 01; 23(1):221-8. PubMed ID: 12792797
    [Abstract] [Full Text] [Related]

  • 13. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A, Burkhardt M, Jung M, Fritzsche F, Ringsdorf M, Schicktanz H, Loening SA, Kristiansen G, Jung K.
    Eur Urol; 2007 May 01; 51(5):1259-66. PubMed ID: 16806661
    [Abstract] [Full Text] [Related]

  • 14. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
    Avgeris M, Koutalellis G, Fragoulis EG, Scorilas A.
    Clin Biochem; 2008 Oct 01; 41(14-15):1140-9. PubMed ID: 18586020
    [Abstract] [Full Text] [Related]

  • 15. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
    de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, Swinkels DW, Schalken JA.
    Cancer Res; 2002 May 01; 62(9):2695-8. PubMed ID: 11980670
    [Abstract] [Full Text] [Related]

  • 16. Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis.
    Neves AF, Araújo TG, Biase WK, Meola J, Alcântara TM, Freitas DG, Goulart LR.
    Clin Biochem; 2008 Oct 01; 41(14-15):1191-8. PubMed ID: 18640109
    [Abstract] [Full Text] [Related]

  • 17. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy.
    Miyake H, Kurahashi T, Hara I, Takenaka A, Fujisawa M.
    BJU Int; 2007 Feb 01; 99(2):315-20. PubMed ID: 17155986
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of NKX3.1 in benign prostatic hyperplasia.
    Irer B, Toylu A, Aslan G, Celebi I, Yorukoglu K, Atabey N.
    Urology; 2009 May 01; 73(5):1140-4. PubMed ID: 18597829
    [Abstract] [Full Text] [Related]

  • 19. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T, Herawi M, Epstein JI, Illei PB.
    Am J Surg Pathol; 2007 Sep 01; 31(9):1351-5. PubMed ID: 17721190
    [Abstract] [Full Text] [Related]

  • 20. Beta-human chorionic gonadotropin in semen: a marker for early detection of prostate cancer?
    Daja MM, Aghmesheh M, Ow KT, Rohde PR, Barrow KD, Russell PJ.
    Mol Urol; 2000 Sep 01; 4(4):421-7. PubMed ID: 11156711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.